Tela Bio Earnings Estimate

TELA Stock  USD 2.35  0.11  4.91%   
The next projected EPS of Tela Bio is estimated to be -0.35875 with future projections ranging from a low of -0.425 to a high of -0.3225. Tela Bio's most recent 12-month trailing earnings per share (EPS TTM) is at -1.69. Please be aware that the consensus of earnings estimates for Tela Bio is based on EPS before non-recurring items and includes expenses related to employee stock options.
 
Covid
Tela Bio is projected to generate -0.35875 in earnings per share on the 31st of December 2024. Tela Bio earnings estimates show analyst consensus about projected Tela Bio EPS (Earning Per Share). It derives the highest and the lowest estimates based on Tela Bio's historical volatility. Many public companies, such as Tela Bio, manage the perception of their earnings on a regular basis to make sure that analyst estimates are accurate. Future earnings calculations are also an essential input when attempting to value a firm. By analyzing Tela Bio's earnings estimates, investors can diagnose different trends across Tela Bio's analyst sentiment over time as well as compare current estimates against different timeframes. The current year's Gross Profit is expected to grow to about 48.4 M, whereas Pretax Profit Margin is forecasted to decline to (0.75).
  
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Tela Bio. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.
For information on how to trade Tela Stock refer to our How to Trade Tela Stock guide.

Tela Bio Earnings Estimation Breakdown

The calculation of Tela Bio's earning per share is based on the data from the past 12 consecutive months, used for reporting the company's financial figures. The next projected EPS of Tela Bio is estimated to be -0.35875 with the future projection ranging from a low of -0.425 to a high of -0.3225. Please be aware that this consensus of annual earnings estimates for Tela Bio is based on EPS before non-recurring items and includes expenses related to employee stock options.
Last Reported EPS
-0.42
-0.42
Lowest
Expected EPS
-0.35875
-0.32
Highest

Tela Bio Earnings Projection Consensus

Suppose the current estimates of Tela Bio's value are higher than the current market price of the Tela Bio stock. In this case, investors may conclude that Tela Bio is overpriced and will exhibit bullish sentiment. On the other hand, if the present value is lower than the stock price, analysts may conclude that the market undervalues the equity. These scenarios may suggest that the market is not as efficient as it should be at the estimation time, and Tela Bio's stock will quickly adjusts to the new information provided by the consensus estimate.
Number of AnalystsHistorical AccuracyLast Reported EPSEstimated EPS for 31st of December 2024Current EPS (TTM)
495.24%
-0.42
-0.35875
-1.69

Tela Bio Earnings History

Earnings estimate consensus by Tela Bio analysts from Wall Street is used by the market to judge Tela Bio's stock performance. Investors also use these earnings estimates to evaluate and project the stock performance into the future in order to make their investment decisions. However, we recommend analyzing not only Tela Bio's upcoming profit reports and earnings-per-share forecasts but also comparing them to our different valuation methods.

Tela Bio Quarterly Gross Profit

12.86 Million

The current year's Price Earnings To Growth Ratio is expected to grow to 0.15, whereas Retained Earnings are forecasted to decline to (303.2 M). As of March 17, 2025, Common Stock Shares Outstanding is expected to decline to about 14.3 M. In addition to that, Net Loss is expected to decline to about (41.9 M).
Hype
Prediction
LowEstimatedHigh
0.122.314.89
Details
Intrinsic
Valuation
LowRealHigh
1.594.176.75
Details
Naive
Forecast
LowNextHigh
0.052.344.92
Details
4 Analysts
Consensus
LowTargetHigh
8.659.5010.55
Details
Note that many institutional investors and large investment bankers can move markets due to the volume of Tela assets they manage. They also follow analysts to some degree and often drive overall investor sentiments towards Tela Bio. With so many stockholders watching consensus numbers, the difference between actual and projected earnings is one of the most critical factors driving Tela Bio's stock price in the short term.

Tela Bio Earnings per Share Projection vs Actual

Actual Earning per Share of Tela Bio refers to what the company shows during its earnings calls or quarterly reports. The Expected EPS is what analysts covering Tela Bio predict the company's earnings will be in the future. The higher the earnings per share of Tela Bio, the better is its profitability. While calculating the Earning per Share, we use the weighted ratio, as the number of shares outstanding can change over time.

Tela Bio Estimated Months Earnings per Share

For an investor who is primarily interested in generating an income out of investing in entities such as Tela Bio, the EPS ratio can tell if the company is intending to increase its current dividend. Although EPS is an essential tool for investors, it should not be used in isolation. EPS of Tela Bio should always be considered in relation to other companies to make a more educated investment decision.

Tela Quarterly Analyst Estimates and Surprise Metrics

Earnings surprises can significantly impact Tela Bio's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported
Fiscal Date
Estimated EPS
Reported EPS
Surprise
2024-11-07
2024-09-30-0.4-0.42-0.02
2024-08-12
2024-06-30-0.47-0.51-0.04
2024-05-09
2024-03-31-0.5-0.230.2754 
2024-03-21
2023-12-31-0.43-0.53-0.123 
2023-11-09
2023-09-30-0.49-0.450.04
2023-08-09
2023-06-30-0.53-0.460.0713 
2023-05-11
2023-03-31-0.56-0.63-0.0712 
2023-03-21
2022-12-31-0.55-0.520.03
2022-11-09
2022-09-30-0.63-0.64-0.01
2022-08-10
2022-06-30-0.62-0.79-0.1727 
2022-05-10
2022-03-31-0.56-0.75-0.1933 
2022-03-21
2021-12-31-0.55-0.59-0.04
2021-11-10
2021-09-30-0.52-0.57-0.05
2021-08-11
2021-06-30-0.52-0.57-0.05
2021-05-13
2021-03-31-0.48-0.56-0.0816 
2021-03-24
2020-12-31-0.49-0.54-0.0510 
2020-11-11
2020-09-30-0.49-0.53-0.04
2020-08-12
2020-06-30-0.59-0.530.0610 
2020-05-12
2020-03-31-0.56-0.63-0.0712 
2020-03-27
2019-12-31-0.59-1.22-0.63106 
2019-12-18
2019-09-30-0.56-0.020.5496 
2019-08-28
2019-06-300-0.47-0.47

About Tela Bio Earnings Estimate

The earnings estimate module is a useful tool to check what professional financial analysts are assuming about the future of Tela Bio earnings. We show available consensus EPS estimates for the upcoming years and quarters. Investors can also examine how these consensus opinions have evolved historically. We show current Tela Bio estimates, future projections, as well as estimates 1, 2, and three years ago. Investors can search for a specific entity to conduct investment planning and build diversified portfolios. Please note, earnings estimates provided by Macroaxis are the average expectations of expert analysts that we track. If a given stock such as Tela Bio fails to match professional earnings estimates, it usually performs purely. Wall Street refers to that as a 'negative surprise.' If a company 'beats' future estimates, it's usually called an 'upside surprise.'
Please read more on our stock advisor page.
Last ReportedProjected for Next Year
Retained Earnings-288.8 M-303.2 M
Retained Earnings Total Equity-246.8 M-259.1 M
Earnings Yield(0.35)(0.37)
Price Earnings Ratio(2.92)(3.07)
Price Earnings To Growth Ratio 0.13  0.15 

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether Tela Bio offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Tela Bio's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Tela Bio Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Tela Bio Stock:
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Tela Bio. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.
For information on how to trade Tela Stock refer to our How to Trade Tela Stock guide.
You can also try the Headlines Timeline module to stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Tela Bio. If investors know Tela will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Tela Bio listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(1.69)
Revenue Per Share
2.789
Quarterly Revenue Growth
0.259
Return On Assets
(0.41)
Return On Equity
(3.42)
The market value of Tela Bio is measured differently than its book value, which is the value of Tela that is recorded on the company's balance sheet. Investors also form their own opinion of Tela Bio's value that differs from its market value or its book value, called intrinsic value, which is Tela Bio's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Tela Bio's market value can be influenced by many factors that don't directly affect Tela Bio's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Tela Bio's value and its price as these two are different measures arrived at by different means. Investors typically determine if Tela Bio is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Tela Bio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.